Alzheimers Disease Biomarker Comprehensive Database (ABCD)

Alzheimers Disease Biomarker Comprehensive Database (ABCD) curates and integrates molecular, imaging, pathway, animal model, and medicinal candidate data related to Alzheimer's disease to support biomarker discovery and translational research.

Key Features:

• Comprehensive Molecular Data: ABCD catalogs proteins, genes, transcription factors, single nucleotide polymorphisms (SNPs), microRNAs (miRNAs), mitochondrial genes, and expressed genes implicated in Alzheimer’s disease.
• Pathway and Animal Model Information: The database links associative pathways with information on animal models used to study AD molecular mechanisms and preclinical findings.
• Medicinal Candidates: ABCD contains entries on potential medicinal candidates relevant to AD therapeutic development.
• Imaging Data: The resource includes brain image data from AD-affected patients for analysis of structural changes associated with the disease.
• Integration with External Resources: Records are cross-referenced with major external databases and resources to provide additional AD-related information.
• Advanced Search Options: The platform supports queries by genes, proteins, pathways, and regulatory elements to extract targeted datasets.

Scientific Applications:

• Genetic Research: Enables identification and characterization of genetic risk factors and variant associations in AD.
• Pathway Analysis: Supports investigation of molecular pathways and interactions implicated in AD pathogenesis.
• Drug Discovery: Facilitates prioritization of medicinal candidates and target validation for therapeutic development.
• Neuroimaging Studies: Provides brain imaging data for studying structural alterations and correlating molecular biomarkers with imaging phenotypes.

Methodology:

No computational methods or processing workflows were specified in the provided description.